Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000937394-05-000014
Filing Date
2005-01-13
Accepted
2005-01-13 17:17:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 HAI_AKC4 akc_4.txt SC 13G/A 8810
  Complete submission text file 0000937394-05-000014.txt   10514
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Subject) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-33655 | Film No.: 05528825
SIC: 2834 Pharmaceutical Preparations

Mailing Address 789 N WATER STREET SUITE 500 MILWAUKEE WI 53202
Business Address 789 N WATER STREET SUITE 500 MILWAUKEE WI 53202 4143477777
HEARTLAND ADVISORS INC (Filed by) CIK: 0000937394 (see all company filings)

EIN.: 391078128 | State of Incorp.: WI | Fiscal Year End: 0930
Type: SC 13G/A